cyclosporine ophthalmic solution
GPTKB entity
Statements (30)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
ophthalmic medication
|
| gptkbp:activeIngredient |
gptkb:cyclosporine
|
| gptkbp:approvedBy |
gptkb:FDA
2003 |
| gptkbp:ATCCode |
gptkb:S01XA18
|
| gptkbp:brand |
gptkb:Restasis
gptkb:Cequa |
| gptkbp:concentration |
0.09%
0.05% |
| gptkbp:developedBy |
gptkb:Allergan
gptkb:Sun_Pharma |
| gptkbp:form |
emulsifier
eye drops |
| https://www.w3.org/2000/01/rdf-schema#label |
cyclosporine ophthalmic solution
|
| gptkbp:legalStatus |
Rx-only
|
| gptkbp:marketedIn |
gptkb:Canada
gptkb:Europe gptkb:United_States |
| gptkbp:mechanismOfAction |
immunosuppressant
increases tear production |
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:routeOfAdministration |
ophthalmic
|
| gptkbp:sideEffect |
eye pain
eye redness eye burning |
| gptkbp:usedFor |
gptkb:keratoconjunctivitis_sicca
gptkb:dry_eye_disease |
| gptkbp:bfsParent |
gptkb:Cequa
|
| gptkbp:bfsLayer |
7
|